At least 400 people across the U.S. have had trouble getting their hands on an Epipen in recent weeks, according to a survey from the advocacy group Food Allergy Research & Education.
Mylan (NSDQ:MYL), which makes the emergency allergy auto-injector, reportedly told the FDA months ago that manufacturing delays were straining its Epipen supply.
Get the full story at our sister site, Drug Delivery Business News.
The post Manufacturing delays lead to Epipen shortage in U.S. appeared first on MassDevice.
from MassDevice https://ift.tt/2wlXTzY
Cap comentari:
Publica un comentari a l'entrada